187 related articles for article (PubMed ID: 37218920)
21. PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation.
Li X; Li X; Hu Y; Liu O; Wang Y; Li S; Yang Q; Lin B
BMC Cancer; 2023 Jun; 23(1):573. PubMed ID: 37349676
[TBL] [Abstract][Full Text] [Related]
22. Genomic and protein expression analysis reveals flap endonuclease 1 (FEN1) as a key biomarker in breast and ovarian cancer.
Abdel-Fatah TM; Russell R; Albarakati N; Maloney DJ; Dorjsuren D; Rueda OM; Moseley P; Mohan V; Sun H; Abbotts R; Mukherjee A; Agarwal D; Illuzzi JL; Jadhav A; Simeonov A; Ball G; Chan S; Caldas C; Ellis IO; Wilson DM; Madhusudan S
Mol Oncol; 2014 Oct; 8(7):1326-38. PubMed ID: 24880630
[TBL] [Abstract][Full Text] [Related]
23. Bioinformatics analysis of the transcriptional expression of minichromosome maintenance proteins as potential indicators of survival in patients with cervical cancer.
Wu B; Xi S
BMC Cancer; 2021 Aug; 21(1):928. PubMed ID: 34404366
[TBL] [Abstract][Full Text] [Related]
24. Comprehensive analysis of lncRNA-mRNA co-expression networks in HPV-driven cervical cancer reveals the pivotal function of LINC00511-PGK1 in tumorigenesis.
Xin X; Jia-Yin Y; Jun-Yang H; Rui W; Xiong-Ri K; Long-Rui D; Liu J; Jue-Yu Z
Comput Biol Med; 2023 Jun; 159():106943. PubMed ID: 37099974
[TBL] [Abstract][Full Text] [Related]
25. Sperm protein 17 is highly expressed in endometrial and cervical cancers.
Li FQ; Liu Q; Han YL; Wu B; Yin HL
BMC Cancer; 2010 Aug; 10():429. PubMed ID: 20712874
[TBL] [Abstract][Full Text] [Related]
26. REG4 is associated with carcinogenesis in the 'intestinal' pathway of intraductal papillary mucinous neoplasms.
Nakata K; Nagai E; Ohuchida K; Aishima S; Hayashi A; Miyasaka Y; Yu J; Mizumoto K; Tanaka M; Tsuneyoshi M
Mod Pathol; 2009 Mar; 22(3):460-8. PubMed ID: 19136934
[TBL] [Abstract][Full Text] [Related]
27. Predictive Values of Programmed Cell Death-Ligand 1 Expression for Prognosis, Clinicopathological Factors, and Response to Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Inhibitors in Patients With Gynecological Cancers: A Meta-Analysis.
Zhang C; Yang Q
Front Oncol; 2020; 10():572203. PubMed ID: 33634012
[TBL] [Abstract][Full Text] [Related]
28. Integrated analysis identifies TfR1 as a prognostic biomarker which correlates with immune infiltration in breast cancer.
Chen F; Fan Y; Hou J; Liu B; Zhang B; Shang Y; Chang Y; Cao P; Tan K
Aging (Albany NY); 2021 Sep; 13(17):21671-21699. PubMed ID: 34518441
[TBL] [Abstract][Full Text] [Related]
29. Comprehensive analysis of the expression, prognostic significance, and regulation pathway of G2E3 in breast cancer.
Shen Y; Xue J; Yu J; Jiang Y; Bu J; Zhu T; Gu X; Zhu X
World J Surg Oncol; 2022 Dec; 20(1):398. PubMed ID: 36517818
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of REG4 confers an independent negative prognosticator in rectal cancers receiving concurrent chemoradiotherapy.
He HL; Lee YE; Shiue YL; Lee SW; Lin LC; Chen TJ; Wu TF; Hsing CH; Huang HY; Wang JY; Li CF
J Surg Oncol; 2014 Dec; 110(8):1002-10. PubMed ID: 25155043
[TBL] [Abstract][Full Text] [Related]
31. Peritoneal washing cytology in gynecologic cancers: long-term follow-up of 355 patients.
Zuna RE; Behrens A
J Natl Cancer Inst; 1996 Jul; 88(14):980-7. PubMed ID: 8667429
[TBL] [Abstract][Full Text] [Related]
32. REG4 independently predicts better prognosis in non-mucinous colorectal cancer.
Kaprio T; Hagström J; Mustonen H; Koskensalo S; Andersson LC; Haglund C
PLoS One; 2014; 9(10):e109600. PubMed ID: 25295732
[TBL] [Abstract][Full Text] [Related]
33. Bioinformatics Analysis Reveals
Ma H; Liu Z; Li H; Guo X; Guo S; Qu P; Wang Y
Comput Math Methods Med; 2021; 2021():8494260. PubMed ID: 34671420
[TBL] [Abstract][Full Text] [Related]
34. Increased Expression of INHBA Is Correlated With Poor Prognosis and High Immune Infiltrating Level in Breast Cancer.
Yu Z; Cheng L; Liu X; Zhang L; Cao H
Front Bioinform; 2022; 2():729902. PubMed ID: 36304286
[No Abstract] [Full Text] [Related]
35. Identification of prognostic significance of BIRC5 in breast cancer using integrative bioinformatics analysis.
Dai JB; Zhu B; Lin WJ; Gao HY; Dai H; Zheng L; Shi WH; Chen WX
Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32043523
[TBL] [Abstract][Full Text] [Related]
36. Elafin is downregulated during breast and ovarian tumorigenesis but its residual expression predicts recurrence.
Caruso JA; Karakas C; Zhang J; Yi M; Albarracin C; Sahin A; Bondy M; Liu J; Hunt KK; Keyomarsi K
Breast Cancer Res; 2014; 16(6):3417. PubMed ID: 25551582
[TBL] [Abstract][Full Text] [Related]
37. ARID1A loss is prevalent in endometrial hyperplasia with atypia and low-grade endometrioid carcinomas.
Werner HM; Berg A; Wik E; Birkeland E; Krakstad C; Kusonmano K; Petersen K; Kalland KH; Oyan AM; Akslen LA; Trovik J; Salvesen HB
Mod Pathol; 2013 Mar; 26(3):428-34. PubMed ID: 23080032
[TBL] [Abstract][Full Text] [Related]
38. MRPL15 is a novel prognostic biomarker and therapeutic target for epithelial ovarian cancer.
Xu H; Zou R; Li F; Liu J; Luan N; Wang S; Zhu L
Cancer Med; 2021 Jun; 10(11):3655-3673. PubMed ID: 33934540
[TBL] [Abstract][Full Text] [Related]
39. Bioinformatics analysis of prognostic significance of COL10A1 in breast cancer.
Zhang M; Chen H; Wang M; Bai F; Wu K
Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32043519
[TBL] [Abstract][Full Text] [Related]
40. Soluble urokinase plasminogen activator receptor in preoperatively obtained plasma from patients with gynecological cancer or benign gynecological diseases.
Riisbro R; Stephens RW; Brünner N; Christensen IJ; Nielsen HJ; Heilmann L; von Tempelhoff GF
Gynecol Oncol; 2001 Sep; 82(3):523-31. PubMed ID: 11520150
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]